Growth Metrics

Catheter Precision (VTAK) Return on Invested Capital (2018 - 2025)

Catheter Precision (VTAK) has disclosed Return on Invested Capital for 5 consecutive years, with 2.14% as the latest value for Q2 2025.

  • On a quarterly basis, Return on Invested Capital changed N/A to 2.14% in Q2 2025 year-over-year; TTM through Jun 2025 was 2.14%, a N/A change, with the full-year FY2022 number at 2.35%, down 67.0% from a year prior.
  • Return on Invested Capital was 2.14% for Q2 2025 at Catheter Precision, up from 3.67% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 1.76% in Q1 2022 to a low of 3.9% in Q1 2023.
  • A 3-year average of 2.65% and a median of 2.41% in 2022 define the central range for Return on Invested Capital.
  • Biggest YoY gain for Return on Invested Capital was -81bps in 2023; the steepest drop was -214bps in 2023.
  • Catheter Precision's Return on Invested Capital stood at 2.48% in 2022, then tumbled by -48bps to 3.67% in 2023, then surged by 42bps to 2.14% in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Return on Invested Capital are 2.14% (Q2 2025), 3.67% (Q3 2023), and 2.88% (Q2 2023).